The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Ovarian Cancer
Open accessAbstract
Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity into account, it is becoming evident that each major histological type has characteristic genetic defects that deregulate specific signaling pathways in the tumor cells. Moreover, within the most common histological types, the molecular pathogenesis of low-grade versus high-grade tumors appears to be largely distinct. Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene-expression patterns of selected subtypes of ovarian cancer. Such models will likely prove useful for studying ovarian cancer biology and for preclinical testing of molecularly targeted therapeutics, which may ultimately lead to better clinical outcomes for women with ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H.-G., Tsang, B. K., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312044200 · Cited by 422
RetractedJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,312
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Self-citationp53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Self-citationKindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
Campbell, I. G., Russell, S. E., Choong, D. Y. H., Montgomery, K. G., Ciavarella, M. L., Hooi, C. S. F., Cristiano, B. E., Pearson, R. B., & Phillips, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2933 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Self-citationSugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
Deregulated cyclin E induces chromosome instability
Spruck, C. H., Won, K.-A., & Reed, S. I. (1999) · Nature · doi:10.1038/45836 · Cited by 692
Grading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A., Deavers, M. T., Lu, K., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 670
Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Screening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
Seidman, J. D., Horkayne-Szakaly, I., Haiba, M., Boice, C. R., Kurman, R. J., & Ronnett, B. M. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101080.35393.16 · Cited by 554
Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers
Wang, Z., Shen, D., Parsons, D. W., Bardelli, A., Sager, J., Szabo, S., Ptak, J., Silliman, N., Peters, B. A., van der Heijden, M. S., et al. (2004) · Science · doi:10.1126/science.1096096 · Cited by 522
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Crum, C. P., Drapkin, R., Miron, A., Ince, T. A., Muto, M., Kindelberger, D. W., & Lee, Y. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328011a21f · Cited by 512
Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., & Slamon, D. J. (2003) · PubMed · Cited by 507
Hough, C. D., Sherman‐Baust, C. A., Pizer, E. S., Montz, F. J., Im, D. D., Rosenshein, N. B., Cho, K. R., Riggins, G. J., & Morin, P. J. (2000) · PubMed · Cited by 502
Self-citationWang, S. E., Narasanna, A., Perez-Torres, M., Xiang, B., Wu, F. Y., Yang, S., Carpenter, G., Gazdar, A. F., Muthuswamy, S. K., & Arteaga, C. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.023 · Cited by 470
High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma
Oda, K., Stokoe, D., Taketani, Y., & McCormick, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2620 · Cited by 466
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462 · cited 1×
“A number of genes shown to be differentially expressed between high-grade and low-grade serous carcinomas are involved in several important cellular properties, including cell-cycle regulation, apoptosis, tumor invasion, and control of local immunity (75, 77).”
BackgroundSato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., & Noguchi, M. (2000) · PubMed · doi:10.11501/3187985 · Cited by 448
Schwartz, D. R., Kardia, S. L. R., Shedden, K., Kuick, R. D., Michailidis, G. C., Taylor, J. M. G., Misek, D. E., WU, R. T., Zhai, Y., Darrah, D. M., et al. (2002) · PubMed · Cited by 430
Self-citationFrequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
OBATA, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix‐Trench, G., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 429
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408 · cited 1×
“For example, tumor protein 53 (TP53) is mutated in half or more of high-grade serous carcinomas (26, 27), and activating mutations of KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) or BRAF (v-raf murine sarcoma viral oncogene homolog) are present in over half of low-grade serous carcinomas and SBTs (28).”
BackgroundSelf-citationOrigins and molecular pathology of ovarian cancer
Bell, D. A. (2005) · Modern Pathology · doi:10.1016/s0893-3952(22)04456-8 · Cited by 387
Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V. R., Awtrey, C. S., Gardner, G. J., Barrett, J. C., Boyd, J., & Birrer, M. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0508 · Cited by 376
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., & Frank, T. S. (1995) · Nature Genetics · doi:10.1038/ng0495-439 · Cited by 372
CHD5 Is a Tumor Suppressor at Human 1p36
Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., & Mills, A. A. (2007) · Cell · doi:10.1016/j.cell.2006.11.052 · Cited by 366
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
Histopathologic Grading of Ovarian Carcinoma: A Review and Proposal
Silverberg, S. G. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200001000-00003 · Cited by 351
Precursor lesions of ovarian epithelial malignancy
Feeley, K. M., & Wells, M. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01042.x · Cited by 351
Lessons from BRCA: the Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
Crum, C. P., Drapkin, R., Kindelberger, D., Medeiros, F., Miron, A., & Lee, Y. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.702 · Cited by 342
Ovarian atypical endometriosis: its close association with malignant epithelial tumours
FUKUNAGA, M., NOMURA, K., ISHIKAWA, E., & USHIGOME, S. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.d01-592.x · Cited by 333
Gene Expression Patterns in Ovarian Carcinomas
Schaner, M. E., Ross, D. T., Ciaravino, G., Sørlie, T., Troyanskaya, O., Diehn, M., Wang, Y. C., Duran, G. E., Sikic, T. L., Caldeira, S., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-05-0279 · Cited by 327
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
Baldwin, R. L., Nemeth, E., Tran, H., Shvartsman, H. S., Cass, I. A., Narod, S. A., & Karlan, B. Y. (2000) · PubMed · Cited by 324
Bonome, T., Lee, J.-Y., Park, D.-C., Radonovich, M., Pise-Masison, C., Brady, J., Gardner, G. J., Hao, K., Wong, W. H., Barrett, J. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2240 · Cited by 319
The Guardian's Little Helper: MicroRNAs in the p53 Tumor Suppressor Network
He, X., He, L., & Hannon, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2672 · Cited by 317
Coordinately up-regulated genes in ovarian cancer.
Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R., & Morin, P. J. (2001) · PubMed · Cited by 315
Self-citationFlesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 315
Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.016 · Cited by 313
Self-citationConnolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Xiang, H., Harris, S. S., Vanderhyden, B. C., & Hamilton, T. C. (2003) · PubMed · Cited by 310
Expression Profiling in Ovarian Clear Cell Carcinoma
Tsuchiya, A., Sakamoto, M., Yasuda, J., Chuma, M., Ohta, T., Ohki, M., Yasugi, T., Taketani, Y., & Hirohashi, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63605-x · Cited by 308
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2509 · Cited by 308
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
WU, R. T., Zhai, Y., Fearon, E. R., & Cho, K. R. (2001) · PubMed · Cited by 304
Self-citationMonitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
Wang, K., Gan, L., Jeffery, E., Gayle, M., Gown, A. M., Skelly, M., Nelson, P. S., Ng, W. V., Schummer, M., Hood, L., et al. (1999) · Gene · doi:10.1016/s0378-1119(99)00035-9 · Cited by 297
p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk, J., Thor, A. D., Beauchamp, R., Merritt, V, Edgerton, S. M., Bell, D. A., & Yandell, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4961 · Cited by 289
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Press, J. Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S. E., Blood, K. A., Smith, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-17 · Cited by 287
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 275
Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer
Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, Jr., Nikrui, N., & Goff, B. A. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0032 · Cited by 272
Blaustein’s Pathology of the Female Genital Tract
Robbie, M. (2003) · Pathology · doi:10.1080/00313020310001602701 · Cited by 267
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Notch3 Gene Amplification in Ovarian Cancer
Park, J. T., Li, M., Nakayama, K., Mao, T.-L., Davidson, B., Zhang, Z., Kurman, R. J., Eberhart, C. G., Shih, I.-M., & Wang, T.-L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3610 · Cited by 259
Self-citationCI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
ALLEN, L. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.012 · Cited by 257
Shimizu, Y., Kamoi, S., Amada, S., Akiyama, F., & Silverberg, S. G. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980301)82:5<893::aid-cncr14>3.0.co;2-w · Cited by 254
Mucinous tumors of the ovary: a review.
Hart, W. R. (2005) · PubMed · Cited by 246
Induction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin E
Bortner, D. M., & Rosenberg, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.453 · Cited by 245
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok, S. C., Bell, D. A., KNAPP, R. C., Fishbaugh, P. M., Welch, W. R., Muto, M. G., Berkowitz, R. S., & Tsao, S. (1993) · PubMed · Cited by 237
In ovarian neoplasms, BRAF , but not KRAS , mutations are restricted to low‐grade serous tumours
Sieben, N. L., Macropoulos, P., Roemen, G. M., Kolkman‐Uljee, S. M., Jan Fleuren, G., Houmadi, R., Diss, T., Warren, B., Al Adnani, M., de Goeij, A. P., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1521 · Cited by 237
Mayr, D., Hirschmann, A., Löhrs, U., & Diebold, J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.029 · Cited by 224
β-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas
Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suárez, A., & Armas, A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65148-6 · Cited by 220
Wang, T.-L., Maierhofer, C., Speicher, M. R., Lengauer, C., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202610899 · Cited by 219
Meng, Q., Xia, C., Fang, J., Rojanasakul, Y., & Jiang, B.-H. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.019 · Cited by 214
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Gemignani, M. L., Schlaerth, A. C., Bogomolniy, F., Barakat, R. R., Lin, O., Soslow, R., Venkatraman, E., & Boyd, J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00264-6 · Cited by 213
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
Ho, C.-L., Kurman, R. J., Dehari, R., Wang, T.-L., & Shih, I.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2067 · Cited by 206
Self-citationMeinhold-Heerlein, I., Bauerschlag, D., Hilpert, F., Dimitrov, P., Sapinoso, L. M., Orlowska-Volk, M., Bauknecht, T., Park, T.-W., Jonat, W., Jacobsen, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208298 · Cited by 205
Kurman, R. J., Visvanathan, K., Roden, R., Wu, T. C., & Shih, I.-M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.005 · Cited by 203
Self-citationDi Cristofano, A., & Ellenson, L. H. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091905 · Cited by 198
Lee, K. W., Kang, N. J., Heo, Y.-S., Rogozin, E. A., Pugliese, A., Hwang, M. K., Bowden, G. T., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3140 · Cited by 194
HLA-G is a potential tumor marker in malignant ascites.
Singer, G., Rebmann, V., Chen, Y., Liu, H. T., Ali, S. Z., REINSBERG, J., McMaster, M., Pfeiffer, K. A., Chan, D. W., Wardelmann, E., et al. (2003) · PubMed · Cited by 194
Self-citationEnomoto, T., Weghorst, C. M., Inoue, M., Tanizawa, O., & Rice, J. M. (1991) · PubMed Central · Cited by 192
Saegusa, M., & Okayasu, I. (2001) · The Journal of Pathology · doi:10.1002/path.856 · Cited by 188
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
Nakayama, K., Nakayama, N., Kurman, R. J., Cope, L., Pohl, G., Samuels, Y., Velculescu, V. E., Wang, T.-L., & Shih, I.-M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2751 · Cited by 187
Self-citationCatasús, L., Bussaglia, E., Rodrı́guez, I., Gallardo, A., Pons, C., Irving, J. A., & Prat, J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.019 · Cited by 181
Schraml, P., Schwerdtfeger, G., Burkhalter, F., Raggi, A., Schmidt, D., Ruffalo, T., King, W., Wilber, K., Mihatsch, M. J., & Moch, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63458-x · Cited by 175
Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
Chan, W.-Y., Cheung, K.-K., Schorge, J. O., Huang, L.-W., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64744-x · Cited by 171
O'Neill, C. J., Deavers, M. T., Malpica, A., Foster, H., & McCluggage, W. G. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000166367.68459.7d · Cited by 164
Eržen, M., Rakar, S., Klančar, B., & Syrjänen, K. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6382 · Cited by 160
Amplicon profiles in ovarian serous carcinomas
Nakayama, K., Nakayama, N., Jinawath, N., Salani, R., Kurman, R. J., Shih, I., & Wang, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22609 · Cited by 152
Self-citationMoreno‐Bueno, G., Gamallo, C., Pérez–Gallego, L., de Mora, J. C., Suárez, A., & Palacios, J. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200106000-00008 · Cited by 148
Characterization of Active Mitogen-Activated Protein Kinase in Ovarian Serous Carcinomas
Hsu, C., Bristow, R. E., Cha, M. S., Wang, B. G., Ho, C., Kurman, R. J., Wang, T., & Shih, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0893 · Cited by 148
Self-citationAmplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
Shih, I., Sheu, J. J., Santillan, A., Nakayama, K., Yen, M. J., Bristow, R. E., VANG, R. S., Parmigiani, G., Kurman, R. J., Trope, C. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504195102 · Cited by 146
Self-citationIchikawa, Y., Nishida, M., Suzuki, H., Yoshida, S., Tsunoda, H., Kubo, T., Uchida, K., & Miwa, M. (1994) · PubMed · Cited by 144
p53 Mutations and Expression in Ovarian Cancers: Correlation with Overall Survival
Wen, W., Reles, A., Runnebaum, I. B., Sullivan‐Halley, J., Bernstein, L., Jones, L. A., Felix, J. C., Kreienberg, R., El‐Naggar, A. K., & Press, M. F. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199901000-00005 · Cited by 143
Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges
Shih, I.-M., & Kurman, R. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0755 · Cited by 142 · cited 1×
“two broad categories, designated Type I and Type II tumors, based on their pattern of tumor progression and molecular genetic changes (137, 138).”
BackgroundSelf-citationA distinct molecular profile associated with mucinous epithelial ovarian cancer
Heinzelmann-Schwarz, V. A., Gardiner‐Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Smith, A. N., Bali, A., Bergh, P. M. V., Baron-Hay, S. E., Scott, C. D., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603003 · Cited by 137
Alternate molecular genetic pathways in ovarian carcinomas of common histological types
Willner, J. B., Wurz, K., Allison, K. H., Galic, V., Garcia, R. L., Goff, B. A., & Swisher, E. M. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.10.007 · Cited by 135
Safran, M., Kim, W. Y., Kung, A. L., Horner, J. W., Depinho, R. A., & Kaelin, W. G. (2003) · Molecular Imaging · doi:10.1162/153535003322750637 · Cited by 134
Wright, K., Wilson, P. J., Morland, S. J., Campbell, I., Walsh, M. D., Hurst, T., Ward, B. G., Cummings, M. C., & Chenevix‐Trench, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<625::aid-ijc1>3.0.co;2-2 · Cited by 134
p53 and p21 Form an Inducible Barrier that Protects Cells against Cyclin E-cdk2 Deregulation
Minella, A. C., Swanger, J., Bryant, E. M., Welcker, M., Hwang, H. C., & Clurman, B. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01225-3 · Cited by 134
Pohl, G., Ho, C., Kurman, R. J., Bristow, R. E., Wang, T., & Shih, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3625 · Cited by 132
Self-citationGilks, C. B. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000130446.84670.93 · Cited by 130
Catasús, L., Gallardo, A., Cuatrecasas, M., & Prat, J. (2007) · Modern Pathology · doi:10.1038/modpathol.3800992 · Cited by 126
Microsatellite instability and alterations in the HMSH2 gene in human ovarian cancer
Fujita, M., Enomoto, T., Yoshino, K., Nomura, T., Buzard, G. S., Inoue, M., & Okudaira, Y. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640602 · Cited by 125
Salani, R., Kurman, R. J., Giuntoli, R. L., Gardner, G. J., Bristow, R. E., Wang, T., & Shih, I. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01039.x · Cited by 120
Self-citationBell, K. A., & Kurman, R. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200011000-00002 · Cited by 118
Farley, J. H., Smith, L. M., Darcy, K. M., Sobel, E. L., O’Connor, D., Henderson, B., Morrison, L. E., & Birrer, M. J. (2003) · PubMed · Cited by 118
Gilks, C. B., Vanderhyden, B. C., Zhu, S., van de Rijn, M., & Longacre, T. A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.039 · Cited by 116
Prevalence of Endometriosis in Ovarian Cancer
Yoshikawa, H., Jimbo, H., Okada, S., Matsumoto, K., Onda, T., Yasugi, T., & Taketani, Y. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000052873 · Cited by 115
Endometrioid carcinoma of the ovary and endometriosis: The association in postmenopausal women
DePriest, P. D., Banks, E. R., Powell, D. E., van Nagell, J. R., Gallion, H. H., Puls, L. E., Hunter, J. E., Kryscio, R. J., & Royalty, M. B. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90079-x · Cited by 113
Wang, C.-J., Horiuchi, A., Imai, T., Ohira, S., Itoh, K., Nikaido, T., Katsuyama, Y., & Konishi, I. (2004) · The Journal of Pathology · doi:10.1002/path.1507 · Cited by 112
Overexpression of Cyclin D1 in Epithelial Ovarian Cancers
Worsley, S. D., Ponder, B. A. J., & Davies, B. R. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1996.4569 · Cited by 106
Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma
LEITAO, M., Soslow, R. A., Baergen, R. N., Olvera, N., ARROYO, C., & Boyd, J. A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.043 · Cited by 103
Molecular Genetic Defects in Endometriosis
Thomas, E. J., & Campbell, I. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000052878 · Cited by 102
Mayr, D. C., Kanitz, V., Anderegg, B., Luthardt, B., Engel, J., Löhrs, U., Amann, G., & Diebold, J. (2006) · American Journal of Clinical Pathology · doi:10.1309/n6x5mb24bp42kp20 · Cited by 97
Nowee, M., Snijders, A., Rockx, D., de Wit, R., Kosma, V.-M., Hämäläinen, K. M., Schouten, J., Verheijen, R. H. M., van Diest, P. J., Albertson, D. G., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2217 · Cited by 96
Okawa, E. R., Gotoh, T., Manne, J., Igarashi, J., Fujita, T., Silverman, K. A., Xhao, H., Mossé, Y. P., White, P. S., & Brodeur, G. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210675 · Cited by 96
Kolasa, I. K., Rembiszewska, A., Janiec–Jankowska, A., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.007 · Cited by 84
Suehiro, Y., Sakamoto, M., Umayahara, K., Iwabuchi, H., Sakamoto, H., Tanaka, N., Takeshima, N., Yamauchi, K., Hasumi, K., Akiya, T., et al. (2000) · Oncology · doi:10.1159/000012137 · Cited by 77
Sagae, S., Kobayashi, K., Nishioka, Y., Sugimura, M., Ishioka, S., Nagata, M., Terasawa, K., Tokino, T., & Kudo, R. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00777.x · Cited by 77
Davidson, B., Givant-Horwitz, V., Lazarovici, P., Risberg, B. Å., Nesland, J. M., Tropé, C. G., SCHAEFER, E. M., & Reich, R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1027347932543 · Cited by 76
Tapper, J., Bützow, R. C., Wahlström, T., Seppälä, M. T., & Knuutila, S. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.304 · Cited by 75
Targeting mTOR for Cancer Treatment
Rubio‐Viqueira, B., & Hidalgo, M. M. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-5133-3_24 · Cited by 71
The Concurrent Expression of p27kip1and Cyclin D1 in Epithelial Ovarian Tumors
Sui, L., Tokuda, M., Ohno, M., Hatase, O., & Hando, T. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5373 · Cited by 67
Reed, E., Yu, J., Davies, A., Gannon, J., & Armentrout, S. L. (2003) · PubMed · Cited by 65
Molecular genetic analysis of ovarian serous cystadenomas
Cheng, E. J., Kurman, R. J., Wang, M., Oldt, R. J., Wang, B. G., Berman, D. M., & Shih, I. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700103 · Cited by 62
Self-citationClear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma.
Tammela, J., Geisler, J. P., Pn, E., et al. (1998) · PubMed · Cited by 59
Clinical and biological significance of HLA-G expression in ovarian cancer
Sheu, J. J., & Shih, I. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.012 · Cited by 58
Self-citationMicrosatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer
Liu, J., Albarracin, C. T., Chang, K., Thompson-Lanza, J. A., Zheng, W., Gershenson, D. M., Broaddus, R. R., & Luthra, R. (2003) · Modern Pathology · doi:10.1038/modpathol.3800017 · Cited by 58
Amemiya, S., Sekizawa, A., Otsuka, J., Tachikawa, T., Saito, H., & Okai, T. (2004) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2004.04.036 · Cited by 56
VANG, R. S., Shih, I., Salani, R., Sugar, E. A., Ayhan, A., & Kurman, R. J. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31816fd555 · Cited by 47
Self-citationHER-2/neu Oncogene Amplification in Stage I And Stage III Ovarian Papillary Serous Carcinoma
Afify, A. M., Werness, B. A., & Mark, H. F. L. (1999) · Experimental and Molecular Pathology · doi:10.1006/exmp.1999.2255 · Cited by 42
Tanaka, T., Tomaru, Y., Nomura, Y., Miura, H., Suzuki, M., & Hayashizaki, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh597 · Cited by 42
Practicalities of Drugging the Phosphatidylinositol-3-Kinase/Akt Cell Survival Signaling Pathway
Powis, G., Ihle, N. T., & Kirkpatrick, D. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0617 · Cited by 41
Dent, J., Hall, G. D., Wilkinson, N., Perren, T. J., Richmond, I., Markham, A. F., Murphy, H., & Bell, S. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600896 · Cited by 39
Leary, R. J., Cummins, J. M., Wang, T., & Velculescu, V. E. (2007) · Nature Protocols · doi:10.1038/nprot.2007.276 · Cited by 23
Germ line and somatic mutations of BRAF V599E in ovarian carcinoma
Ueda, M., Eisaku, T. O. J. I., & Noda, S. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00853.x · Cited by 15
Cited by
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Self-citationEvaluating cell lines as tumour models by comparison of genomic profiles
Domcke, S., Sinha, R., Levine, D. A., Sander, C., & Schultz, N. (2013) · Nature Communications · doi:10.1038/ncomms3126 · Cited by 1,418
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Self-citation
Metadata
- Authors
- Cho, K. R., & Shih, I.-M.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2009-02-01
- Volume
- 4
- Issue
- 1
- Pages
- 287-313
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W4212835986
- Cited by
- 694
- References
- 133
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.